NEVVI Medicare utilization intelligence
Compare this code with others →
Market snapshot

Nationwide CY2023

Medicare Part B FFS · CY2023 · as published by CMS

Jump to the result views

G0465 Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other HCPCS · Skin procedure
Classification Procedure › Skin (CMS RBCS)
First observed 2023
National scale 102 services · est. ▼ 21.1% YoY · 11 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 51 observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window

See it in full: sestamibi, the nuclear heart-imaging tracer (A9500), in Arizona is open as a live example — every paid panel, on real data.

View the live example →
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Filter results:
Market summary

This market's Overview — its estimated all-Medicare volume, national benchmarks, and what the field charges and is paid — is part of Explore.

See what Medicare pays

An Explore subscription, $249 a seat a year, opens the Overview on every code, group and clinician page, including what the market charges and is paid.

It comes with 25 credits a seat a year for Deep Dives, which open the rest.

Subscribe to Explore →

View the live example →

Included in Explore. Part of a Deep Dive.
Continue from here